Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$924K Sell
10,184
-90
-0.9% -$8.21K 0.26% 62
2026
Q1
$1.05M Hold
10,274
0.3% 49
2025
Q4
$1.29M Sell
10,274
-75
-0.7% -$9.55K 0.38% 48
2025
Q3
$1.39M Sell
10,349
-764
-7% -$100K 0.43% 44
2025
Q2
$1.51M Sell
11,113
-40
-0.4% -$5.28K 0.49% 44
2025
Q1
$1.48M Sell
11,153
-6
-0.1% -$764 0.5% 45
2024
Q4
$1.26M Buy
11,159
+22
+0.2% +$2.54K 0.41% 51
2024
Q3
$1.27M Sell
11,137
-232
-2% -$25.4K 0.4% 48
2024
Q2
$1.18M Sell
11,369
-320
-3% -$33.9K 0.37% 51
2024
Q1
$1.33M Hold
11,689
0.44% 48
2023
Q4
$1.29M Sell
11,689
-125
-1% -$12.5K 0.45% 45
2023
Q3
$1.14M Buy
11,814
+200
+2% +$21K 0.42% 45
2023
Q2
$1.27M Buy
11,614
+265
+2% +$28.2K 0.44% 46
2023
Q1
$1.15M Hold
11,349
0.43% 46
2022
Q4
$1.25M Sell
11,349
-23,109
-67% -$2.39M 0.47% 46
2022
Q3
$3.33M Buy
34,458
+22,972
+200% +$2.45M 0.44% 46
2022
Q2
$1.25M Buy
11,486
+256
+2% +$29.1K 0.47% 45
2022
Q1
$1.33M Hold
11,230
0.44% 46
2021
Q4
$1.58M Sell
11,230
-1,068
-9% -$137K 0.52% 42
2021
Q3
$1.45M Buy
12,298
+75
+0.6% +$9.21K 0.53% 43
2021
Q2
$1.42M Buy
12,223
+50
+0.4% +$5.83K 0.51% 47
2021
Q1
$1.46M Hold
12,173
0.58% 41
2020
Q4
$1.33M Hold
12,173
0.55% 46
2020
Q3
$1.32M Sell
12,173
-100
-0.8% -$10.1K 0.63% 40
2020
Q2
$1.12M Hold
12,273
0.59% 45
2020
Q1
$969K Sell
12,273
-182
-1% -$15.2K 0.65% 41
2019
Q4
$1.08M Sell
12,455
-77
-0.6% -$6.45K 0.55% 46
2019
Q3
$1.05M Sell
12,532
-116
-0.9% -$9.86K 0.56% 45
2019
Q2
$1.06M Sell
12,648
-2,475
-16% -$195K 0.56% 46
2019
Q1
$1.21M Sell
15,123
-19,000
-56% -$1.41M 0.61% 44
2018
Q4
$2.47M Buy
+34,123
New +$2.4M 1.47% 32

Other funds holding ABT

O'Brien Greene & Co's ABT Position: Q2 2026 in Review

O'Brien Greene & Co reduced its Abbott (ABT) stake by 0.88% in Q2 2026, selling an estimated $8.21K and leaving 10,184 shares worth $924K. The position accounts for 0.26% of the portfolio, ranked #62.

O'Brien Greene & Co first reported a position in ABT in Q4 2018 and has held it in 31 quarters since. The position peaked at $3.33M in Q3 2022. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • O'Brien Greene & Co held 10,184 shares of Abbott worth $924K as of Q2 2026.
  • O'Brien Greene & Co sold 90 Abbott shares in Q2 2026, an estimated $8.21K.
  • Abbott made up 0.26% of O'Brien Greene & Co's portfolio in Q2 2026, its #62 holding.
  • O'Brien Greene & Co first reported a position in Abbott in Q4 2018 and has held it in 31 quarters since.
  • O'Brien Greene & Co's Abbott position peaked at $3.33M in Q3 2022.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on O'Brien Greene & Co's 13F filing for Q2 2026, filed 6 Aug 2026.